En
  • En English
  • De Deutsch
  • Fr Français
  • Sp Español
  • Ru Русский
  • It Italiano
  • Pt Português
  • Ua Українська
136 results

    OrientationOrientation
    PeoplePeople
    CategoryCategory
    ColorColor
    EditorialEditorial
    Safe SearchSafe Search
    Clear
    Hide
    Illustration of antibodies (yellow and blue) responding to an infection with the new coronavirus SARS-CoV-2 (red) — Stock Photo
    Illustration of antibodies (yellow and blue) responding to an infection with the new coronavirus SARS-CoV-2 (red)
    Molecular models of antibody structures, digital illustration. — Stock Photo
    Molecular models of antibody structures, digital illustration.
    3d illustration of antibodies attacking virus particles. — Stock Photo
    3d illustration of antibodies attacking virus particles.
    Interaction between virus and dendritic cell, computer illustration. Dendritic cells play a crucial role in initiating immune responses against viruses. They recognise incoming viruses and present their antigens to T cells. — Stock Photo
    Interaction between virus and dendritic cell, computer illustration. Dendritic cells play a crucial role in initiating immune responses against viruses. They recognise incoming viruses and present their antigens to T cells.
    3d illustration of antibodies attacking virus particles. — Stock Photo
    3d illustration of antibodies attacking virus particles.
    Lassa virus particles, digital illustration. — Stock Photo
    Lassa virus particles, digital illustration.
    Colored scanning electron micrograph of protective dendritic cell of immune system. — Stock Photo
    Colored scanning electron micrograph of protective dendritic cell of immune system.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Female medical specialist in protective uniform, latex gloves and face mask doing nasal coronavirus test on African American mature woman patient in clinic during virus outbreak — Stock Photo
    Female medical specialist in protective uniform, latex gloves and face mask doing nasal coronavirus test on African American mature woman patient in clinic during virus outbreak
    Active CAR T-cells cancer immunotherapy, medical illustration. — Stock Photo
    Active CAR T-cells cancer immunotherapy, medical illustration.
    Antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2 and destruction of the virus, conceptual illustration — Stock Photo
    Antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2 and destruction of the virus, conceptual illustration
    Immune system T-lymphocytes cells binding antigen, digital illustration. — Stock Photo
    Immune system T-lymphocytes cells binding antigen, digital illustration.
    Illustration of anti-HIV-1 (human immunodeficiency virus-1) antibodies complexed with mimotope peptides — Stock Photo
    Illustration of anti-HIV-1 (human immunodeficiency virus-1) antibodies complexed with mimotope peptides
    Digital artwork of white blood cells attacking red illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking red illuminated cancer cell.
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer — Stock Photo
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer
    Immune system T-lymphocytes cells binding antigen, digital illustration. — Stock Photo
    Immune system T-lymphocytes cells binding antigen, digital illustration.
    Magnified digital illustration of antibody cell. — Stock Photo
    Magnified digital illustration of antibody cell.
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center) — Stock Photo
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center)
    T-cell receptor-MHC-antigen complex — Stock Photo
    T-cell receptor-MHC-antigen complex
    Lassa virus particles, digital illustration. — Stock Photo
    Lassa virus particles, digital illustration.
    Immune system T-lymphocytes cells binding antigen, digital illustration. — Stock Photo
    Immune system T-lymphocytes cells binding antigen, digital illustration.
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment. — Stock Photo
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment.
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer — Stock Photo
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer
    Neutrophil is a granulocyte, a part of the innate immune system. — Stock Photo
    Neutrophil is a granulocyte, a part of the innate immune system.
    Illustration of antibodies responding to an infection with the SARS-CoV-2 coronavirus (centre). The virus causes a mild respiratory illness (Covid-19) that can develop into pneumonia and be fatal in some cases — Stock Photo
    Illustration of antibodies responding to an infection with the SARS-CoV-2 coronavirus (centre). The virus causes a mild respiratory illness (Covid-19) that can develop into pneumonia and be fatal in some cases
    Digital artwork of white blood cells attacking green illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking green illuminated cancer cell.
    Illustration of antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2 — Stock Photo
    Illustration of antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer — Stock Photo
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center) — Stock Photo
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center)
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center) — Stock Photo
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center)
    3d illustration of antibodies attacking virus particles. — Stock Photo
    3d illustration of antibodies attacking virus particles.
    3d illustration of antibodies attacking virus particles. — Stock Photo
    3d illustration of antibodies attacking virus particles.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment. — Stock Photo
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment.
    Antibodies attacking coronavirus particle, illustration. — Stock Photo
    Antibodies attacking coronavirus particle, illustration.
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center) — Stock Photo
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center)
    Digital artwork of white blood cells attacking red illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking red illuminated cancer cell.
    3d illustration of antibodies attacking virus particles. — Stock Photo
    3d illustration of antibodies attacking virus particles.
    Digital artwork of white blood cells attacking illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking illuminated cancer cell.
    RNA vaccine, conceptual illustration. Close-up of human cells expressing viral proteins (red) after vaccination with RNA (ribonucleic acid, blue helix) vaccine. viral proteins will provoke immune response, priming body against infection — Stock Photo
    RNA vaccine, conceptual illustration. Close-up of human cells expressing viral proteins (red) after vaccination with RNA (ribonucleic acid, blue helix) vaccine. viral proteins will provoke immune response, priming body against infection
    Illustration of antigen-presenting cell activity of dendritic cells through membrane-bound histocompatibility complex molecules. — Stock Photo
    Illustration of antigen-presenting cell activity of dendritic cells through membrane-bound histocompatibility complex molecules.
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center) — Stock Photo
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center)
    Interaction between virus and dendritic cell, computer illustration. Dendritic cells play a crucial role in initiating immune responses against viruses. They recognise incoming viruses and present their antigens to T cells. — Stock Photo
    Interaction between virus and dendritic cell, computer illustration. Dendritic cells play a crucial role in initiating immune responses against viruses. They recognise incoming viruses and present their antigens to T cells.
    Antibody blocking programmed cell death, illustration. — Stock Photo
    Antibody blocking programmed cell death, illustration.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Digital artwork of white blood cells attacking red illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking red illuminated cancer cell.
    Digital artwork of white blood cells attacking red illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking red illuminated cancer cell.
    Dendritic cells, illustration. Dendritic cells are a component of the body's immune system. The cell gets it name from the long membrane extensions off the cell body, which look like the dendrites of a nerve cell — Stock Photo
    Dendritic cells, illustration. Dendritic cells are a component of the body's immune system. The cell gets it name from the long membrane extensions off the cell body, which look like the dendrites of a nerve cell
    Dendritic cell, computer illustration. A dendritic cell is a type of white blood cell. It is an antigen-presenting cell (APC), which presents antigens to T lymphocytes. — Stock Photo
    Dendritic cell, computer illustration. A dendritic cell is a type of white blood cell. It is an antigen-presenting cell (APC), which presents antigens to T lymphocytes.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Flu virus particle structure — Stock Photo
    Flu virus particle structure
    T lymphocyte (orange) attached to a cancer cell (blue), illustration. T lymphocytes are a type of white blood cell which matures in the thymus — Stock Photo
    T lymphocyte (orange) attached to a cancer cell (blue), illustration. T lymphocytes are a type of white blood cell which matures in the thymus
    Illustration of leucocyte cell surrounded by antibodies on black background. — Stock Photo
    Illustration of leucocyte cell surrounded by antibodies on black background.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Digital artwork of white blood cells attacking red illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking red illuminated cancer cell.
    Illustration of antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2 (sphere) — Stock Photo
    Illustration of antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2 (sphere)
    Lassa virus particles, digital illustration. — Stock Photo
    Lassa virus particles, digital illustration.
    Antibodies attacking coronavirus particle, illustration. — Stock Photo
    Antibodies attacking coronavirus particle, illustration.
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center) — Stock Photo
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center)